StocksNovozymes B A/SNZYM-B.CO

NZYM-B.CO

Novozymes B A/S

374.14 -6.76 (-1.77%)
Prices By Xignite, in DKK Market Closed
Trade
S
374.14
B
375.46

Overview

Prev Close380.90
Day's Range 367.15 - 377.83
52 Week Range 361.86 - 544.71
Average Volume (3m)280.09K
1-Year Return-16.67%
Beta0.7625
Market Cap105.16B
P/E Ratio33.91
Revenue16.25B
EPS11.2245
Dividend (Yield)5 (1.34%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.721/04/202206/07/202212/09/2022375.00400.00425.00450.00475.00500.00
Chart times in UTC
Industry Chemicals Specialty
CEO Ester Baiget, MBA
Employees 6,527

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Novozymes B A/S's revenues increased by 6.70% and amounted to 14.95B. Net income increased by 11.29% to 3.15B. Net assets increased by 8.56% to 12.21B and EPS increased from 10.02 to 11.23.
NZYM-B.CO's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
56.19%
Net Profit Margin
21.41%
Operating Margin
25.06%
Return On Investment
22.05%
09/21
12/21
03/22
06/22
Total Revenue
3.76B
3.83B
4.37B
4.29B
Gross Profit
2.18B
2.15B
2.43B
2.38B
Operating Income
1.09B
767M
1.13B
1.09B
Net Income
843M
623M
839M
817M